SCHEMBL8312251

SCHEMBL8312251

CCc1cccc2c1C(C)CO2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.37
SLC6A2 P23975 2/20 0.37
SLC6A4 P31645 1/20 0.37
TP53 P04637 2/20 0.37
CTSB P07858 1/20 0.37
GABRA1 P14867 2/20 0.36
GABRB2 P47870 2/20 0.36
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36
MAOA P21397 1/20 0.35
MAP3K14 Q99558 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
MAPT P10636 1/20 0.34
THRB P10828 1/20 0.34
MAPK1 P28482 1/20 0.34
KMT2A Q03164 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
BCHE P06276 1/20 0.34
ACHE P22303 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20889268 0.77 NOS3 (0.43) KDM4EMEN1MAPTTHRBKMT2A
SCHEMBL13592845 0.76 MAP3K14 (0.53) CYP2D6SLC6A2SLC6A4TP53MAP3K14
SCHEMBL29955655 0.75 MEN1 (0.37) TP53MAP3K14KDM4EMEN1MAPT
SCHEMBL19682790 0.75 MEN1 (0.37) TP53MAP3K14KDM4EMEN1MAPT
SCHEMBL30456278 0.74 CYP19A1 (0.38) CYP2D6TP53MAP3K14KDM4EMEN1
SCHEMBL25723204 0.74 CYP19A1 (0.38) CYP2D6TP53MAP3K14KDM4EMEN1
SCHEMBL2479116 0.74 CHRNB4 (0.36) TP53MAP3K14KDM4EMEN1MAPT
SCHEMBL2047603 0.74 MAP3K14 (0.40) MAOAMAP3K14THRBBCHEACHE
SCHEMBL19827781 0.72 CTSB (0.35) SLC6A2SLC6A4TP53CTSBGABRA1
SCHEMBL12677304 0.72 CYP2C9 (0.39) MAP3K14KDM4ECYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004103998-A1 QUINOLINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS GLAXO GROUP LIMITED (GB) 2004-12-02 WO disclosed